Daniela Segalerba
Overview
Explore the profile of Daniela Segalerba including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
118
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Morini M, Barco S, Ardito M, Cafaro A, Pigliasco F, Rossi L, et al.
Oncologist
. 2025 Feb;
30(2).
PMID: 39945419
Background: GD2 ganglioside, a known specific marker for neuroblastoma (NB), exists in different lipoforms, including C18 and C20, which are distinguished by the length of their fatty acid chains. C18...
2.
Morini M, Raggi F, Bartolucci M, Petretto A, Ardito M, Rossi C, et al.
Cells
. 2023 Nov;
12(21).
PMID: 37947594
Neuroblastoma (NB) is the most common extracranial solid tumor during infancy, causing up to 10% of mortality in children; thus, identifying novel early and accurate diagnostic and prognostic biomarkers is...
3.
Raggi F, Cangelosi D, Consolaro A, Rossi C, Pelassa S, Cortese K, et al.
Clin Transl Med
. 2022 Sep;
12(10):e1067.
PMID: 36178089
No abstract available.
4.
DAcierno M, Resaz R, Iervolino A, Nielsen R, Sardella D, Siccardi S, et al.
J Am Soc Nephrol
. 2022 Jul;
33(10):1864-1875.
PMID: 35820785
Background: Mutations in , which encodes the intracellular glucose transporter G6PT, cause the rare glycogen storage disease type 1b (GSD1b). A long-term consequence of GSD1b is kidney failure, which requires...
5.
Resaz R, Cangelosi D, Segalerba D, Morini M, Uva P, Bosco M, et al.
Int J Mol Sci
. 2022 Jan;
23(1).
PMID: 35008754
Glycogen storage disease type Ia (GSDIa) is an inherited metabolic disorder caused by mutations in the enzyme glucose-6-phosphatase-α (G6Pase-α). Affected individuals develop renal and liver complications, including the development of...
6.
Resaz R, Raggi F, Segalerba D, Lavarello C, Gamberucci A, Bosco M, et al.
Mol Genet Metab Rep
. 2021 Oct;
29:100813.
PMID: 34712576
Glycogen Storage Disease type 1b (GSDIb) is a genetic disorder with long term severe complications. Accumulation of the glucose analog 1,5-anhydroglucitol-6-phosphate (1,5AG6P) in neutrophils inhibits the phosphorylation of glucose in...
7.
Resaz R, Cangelosi D, Morini M, Segalerba D, Mastracci L, Grillo F, et al.
Dis Model Mech
. 2020 Jul;
13(9).
PMID: 32620541
Most patients affected by glycogen storage disease type 1a (GSD1a), an inherited metabolic disorder caused by mutations in the enzyme glucose-6-phosphatase-α (G6Pase-α), develop renal and liver complications, including the development...
8.
Morini M, Cangelosi D, Segalerba D, Marimpietri D, Raggi F, Castellano A, et al.
Cancers (Basel)
. 2019 Oct;
11(10).
PMID: 31575060
Despite intensive treatment, 50% of children with high-risk neuroblastoma (HR-NB) succumb to their disease. Progression through current trials evaluating the efficacy of new treatments for children with HR disease usually...
9.
Cangelosi D, Resaz R, Petretto A, Segalerba D, Ognibene M, Raggi F, et al.
J Proteome Res
. 2019 Jun;
18(7):2965-2978.
PMID: 31173686
Glycogen storage disease type 1a (GSD-1a) is a rare genetic disease caused by mutations in the catalytic subunit of the enzyme glucose-6-phosphatase-alpha (G6Pase-α). The majority of patients develop long-term complications...
10.
Resaz R, Rosa F, Grillo F, Basso L, Segalerba D, Puglisi A, et al.
Dis Model Mech
. 2019 Mar;
12(4).
PMID: 30898969
Hepatocellular adenomas (HCAs) are benign tumors, of which the most serious complications are hemorrhage and malignant transformation to hepatocellular carcinoma (HCC). Among the various subtypes of HCA, the β-catenin-activated subtype...